PRESS RELEASE published on 07/17/2024 at 22:00, 1 year 4 months ago Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants Pfizer et Valneva finalisent la vaccination primaire de l'essai de Phase 3 VALOR contre la maladie de Lyme, avec VLA15. Suivi des participants pour mesurer l'incidence de la maladie Valneva Maladie De Lyme Pfizer Phase 3 VALOR Vaccination Primaire
PRESS RELEASE published on 07/17/2024 at 22:00, 1 year 4 months ago Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
BRIEF published on 06/05/2024 at 07:05, 1 year 6 months ago Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Executive Changes Corporate Update Valneva Shareholder Meeting
BRIEF published on 06/05/2024 at 07:05, 1 year 6 months ago Valneva annonce la mise à disposition de la documentation pour son Assemblée Générale Mixte et fait le point sur l'entreprise Assemblée Générale Valneva Mise À Jour De L'entreprise Changements À La Direction
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 6 months ago Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 6 months ago Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction Documents Préparatoires Valneva Assemblée Générale Mixte Équipe De Direction Kendra Wergin
BRIEF published on 05/21/2024 at 07:05, 1 year 6 months ago Valneva nomme le Dr Hanneke Schuitemaker comme Directeur Scientifique Nomination R&D Valneva Dr Hanneke Schuitemaker Vaccins
BRIEF published on 05/21/2024 at 07:05, 1 year 6 months ago Valneva appoints Dr Hanneke Schuitemaker as Scientific Director Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
PRESS RELEASE published on 05/21/2024 at 07:00, 1 year 6 months ago Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique, renforçant ainsi son équipe de direction. Le Dr Schuitemaker apportera son expertise en R&D pour développer des solutions vaccinales innovantes R&D Valneva Dr Hanneke Schuitemaker Vaccins Directeur Scientifique
PRESS RELEASE published on 04/18/2024 at 16:01, 1 year 7 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung für Valneva SE mit Kursziel von €8,60 nach positiven Ergebnissen und Schuldenerlass. Analyse von Analyst Simon Scholes, CFA Research Update Kaufempfehlung Valneva Simon Scholes Schuldenerlass
Published on 12/05/2025 at 02:35, 10 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 29 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 34 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 35 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 20 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 26 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 3 hours 50 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 50 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 52 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 20 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025